Clinical and laboratory features: How they influence immunotherapy response in non-small cell lung cancer

被引：0
|
作者：
Gomes, R. E. [1 ]
Almodovar, T. [2 ]
机构：
[1] Hosp Garcia Orta, Pulmonol, Almada, Portugal
[2] Inst Portugues Oncol Francisco Gentil, Pulmonol, Lisbon, Portugal
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1925
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1324P
引用
收藏
页码：S1015 / S1015
页数：1
相关论文
共 50 条
  • [41] Influence of pre-treatment nutrition and inflammation on immunotherapy response in non-small cell lung cancer
    Robinson, Lary A.
    Kim, Youngchul
    Buro, Acadia
    Hogue, Stephanie R.
    Bailey, Alexis
    DeNicola, Gina M.
    Pierce, Christine
    Umbarger, Mark
    Byrd, Doratha A.
    CANCER RESEARCH, 2024, 84 (06)
  • [42] The influence of circulating tumor DNA analysis on response to immunotherapy in non-small cell lung cancer (NSCLC)
    Grinberg, R.
    Roisman, L. C.
    Geva, S.
    Soussan-Gutman, L.
    Dvir, A.
    Yair, R.
    Twito, T.
    Larman, R.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S35 - S36
  • [43] Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives
    Ciarmiello, Andrea
    Fonti, Rosa
    Giovacchini, Giampiero
    Del Vecchio, Silvana
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (06) : 483 - 485
  • [44] Gut microbiome affects the response to immunotherapy in non-small cell lung cancer
    Ren, Shengnan
    Feng, Lingxin
    Liu, Haoran
    Mao, Yuke
    Yu, Zhuang
    THORACIC CANCER, 2024, 15 (14) : 1149 - 1163
  • [45] The Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
    Grinberg, R.
    Roisman, L.
    Geva, S.
    Lefterova, M.
    Quinn, K.
    Gutman, L. Soussan
    Dvir, A.
    Yair, R.
    Twito, T.
    Lanman, R.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S925 - S926
  • [46] Dendritic cell immunotherapy in non-small cell lung cancer
    Choi, Y.
    Chung, J.
    Shin, H.
    Cho, G.
    Sohn, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer
    Huang, Dingzhi
    Lin, Gen
    Chu, Qian
    Hu, Yi
    Wang, Jun
    Wang, Zhijie
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Liu, Yutao
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    THORACIC CANCER, 2023, 14 (34) : 3421 - 3429
  • [48] Immunotherapy for non-small cell lung cancer: current concepts and clinical trials
    Mayor, Marissa
    Yang, Neng
    Sterman, Daniel
    Jones, David R.
    Adusumilli, Prasad S.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (05) : 1324 - 1333
  • [49] Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service
    Rich, Anna L.
    Tata, Laila J.
    Free, Catherine M.
    Stanley, Rosamund A.
    Peake, Michael D.
    Baldwin, David R.
    Hubbard, Richard B.
    THORAX, 2011, 66 (12) : 1078 - 1084
  • [50] Clinical Parameters Combined With Radiomics Features to Predict the Efficacy of Immunotherapy for Advanced Non-Small Cell Lung Cancer
    Zhao, Q.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E461 - E461
12345